Formulation Design of Glucuronoxylan-Based Stimuli-Responsive Microparticles for Zero-Order Drug Delivery

Key Points

• Zero-order drug delivery achieved through glucuronoxylan-based microparticles, allowing consistent drug release.
• Key evidence indicates that these microparticles can deliver drugs at a steady rate over time, enhancing efficacy.
• Observational analysis of formulation features highlights the stimuli-responsive behavior of the microparticles.
• Supports the potential for advanced drug delivery systems; further studies needed for clinical application.